A detailed history of Brewin Dolphin LTD transactions in Baxter International Inc stock. As of the latest transaction made, Brewin Dolphin LTD holds 1,500 shares of BAX stock, worth $50,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,500 -0.0%
Holding current value
$50,130
Previous $116,000 17.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Nov 14, 2022

SELL
$76.85 - $89.45 $7,684 - $8,945
-100 Reduced 6.25%
1,500 $116,000
Q4 2021

Nov 14, 2022

BUY
$74.57 - $87.19 $119,311 - $139,504
1,600 New
1,600 $137,000
Q3 2021

Nov 09, 2023

SELL
$73.77 - $83.61 $7,377 - $8,361
-100 Reduced 2.74%
3,556 $286 Million
Q1 2021

Nov 09, 2023

SELL
$76.38 - $86.03 $38,190 - $43,015
-500 Reduced 12.03%
3,656 $308 Million
Q4 2020

Nov 09, 2023

SELL
$75.39 - $82.36 $21,561 - $23,554
-286 Reduced 6.44%
4,156 $333 Million
Q2 2020

Nov 09, 2023

BUY
$78.66 - $94.14 $105,561 - $126,335
1,342 Added 43.29%
4,442 $382 Million
Q1 2020

Nov 09, 2023

SELL
$71.57 - $93.3 $29,916 - $38,999
-418 Reduced 11.88%
3,100 $252 Million
Q3 2019

Nov 09, 2023

BUY
$81.4 - $89.78 $5,698 - $6,284
70 Added 2.03%
3,518 $308 Million
Q2 2019

Nov 09, 2023

BUY
$73.44 - $82.41 $5,948 - $6,675
81 Added 2.41%
3,448 $282 Million
Q1 2019

Nov 09, 2023

BUY
$64.48 - $81.31 $59,128 - $74,561
917 Added 37.43%
3,367 $274 Million
Q2 2018

Nov 09, 2023

SELL
$63.43 - $75.41 $14,588 - $17,344
-230 Reduced 8.58%
2,450 $181 Million
Q4 2017

Nov 09, 2023

BUY
$61.45 - $66.05 $5,530 - $5,944
90 Added 3.47%
2,680 $173 Million
Q3 2017

Nov 09, 2023

BUY
$59.5 - $64.61 $64,855 - $70,424
1,090
2,590 $163 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.